Author:
Terrell Mark R.,Walenga Jeanine M.,Koza Michael J.,Pifarré Roque
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference17 articles.
1. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting;Levy;Circulation,1995
2. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass;Blauhut;J Thorac Cardiovasc Surg,1991
3. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study;Cosgrove;Ann Thorac Surg,1992
4. Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgery;Koza;Thromb Res,1993
5. Can heparin be replaced by LMW heparin in cardiopulmonary bypass surgery?;Walenga;Thromb Haemost,1993
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献